Placenta accreta significantly contributes to maternal morbidity and mortality. We evaluated whether planned delivery and experienced, team-managed surgical intervention results in improved outcomes. We also examined whether risk factors differed for accreta, increta, and percreta and evaluated whether excess lower segment uterine vascularity correlates with disease severity.
Methods:
We retrospectively analyzed patients before versus after institution of a management protocol. Of the 58 044 deliveries over 10 years, there were 67 women whose pregnancies were histopathologically confirmed as placenta accreta, increta, or percreta (1/866). Clinical outcome measures were estimated blood loss (EBL), packed red blood cells (pRBCs) transfused, maternal and fetal complications, intensive care unit admission, and length of stay.
Results:
There were no maternal or infant deaths. In the managed cohort, EBL was reduced by 48% (P < .001), intraoperative pRBCs transfused by 40% (P < .01), total transfused pRBCs per case by 50% (P < .01), and surgical intensive care unit admissions by >50% (P < .01). Assessment of maternal risk factors by diagnosis revealed marked differences between accreta versus increta and percreta. Clinically assessed excess vascularity of the lower uterine segment correlated with disease severity. The incidence of neonatal complications was similar in both cohorts.
Conclusions:
Targeted delivery at 34 weeks and team-managed diagnosis, treatment, and care of patients with placenta accreta were associated with improved maternal, but not neonatal outcomes.
KnightMCallaghanWMBergC. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9:55.
2.
KnightM. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG. 2007;114(11):1380–1387.
3.
KastnerESFigueroaRGarryDMaulikD. Emergency peripartum hysterectomy: experience at a community teaching hospital. Obstet Gynecol. 2002;99(6):971–975.
4.
MuenchMVBaschatAAOyeleseYKushMLMightyHEMalinowAM. Gravid hysterectomy: a decade of experience at an academic referral center. J Reprod Med. 2008;53(4):271–278.
KhongTY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol. 2008;61(12):1243–1246.
7.
MazouniCGorincourGJuhanVBretelleF. Placenta accreta: a review of current advances in prenatal diagnosis. Placenta. 2007;28(7):599–603.
8.
TantbirojnPCrumCPParastMM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008;29(7):639–645.
9.
WuSKocherginskyMHibbardJU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–1461.
10.
ACOG Committee opinion. Number 266, January 2002: placenta accreta. Obstet Gynecol. 2002;99(1):169–170.
11.
MillerDACholletJAGoodwinTM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177(1):210–214.
12.
BelfortMA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–439.
13.
Esh-BroderEArielIAbas-BashirNBdolahYCelnikierDH. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG. 2011;118(9):1084–1089.
14.
MazouniCPalacios-JaraquemadaJMDeterRJuhanVGamerreMBretelleF. Differences in the management of suspected cases of placenta accreta in France and Argentina. Int J Gynaecol Obstet. 2009;107(1):1–3.
15.
WarshakCRRamosGAEskanderR. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65–69.
16.
EllerAGPorterTFSoissonPSilverRM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–654.
17.
OlsenIEGrovemanSALawsonMLClarkRHZemelBS. New intrauterine growth curves based on United States data. Pediatrics. 2010;125(2):e214–e224.
18.
Palacios JaraquemadaJMBrunoCH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand. 2005;84(8):716–724.
19.
JainNJDenkCEValenteSSchollT. 2007Pregnancy Risk Assessment Monitoring System (NJ-PRAMS): A survey for healthier babies in New Jersey. Pre-pregnancy weight status and pregnancy weight gain. http://www.nj.gov/health/fhs/professional/prams.shtmlAccessed November 12, 2013.
20.
CedergrenMI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–224.
21.
StotlerBPadmanabhanADevinePWrightJSpitalnikSLSchwartzJ. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51(12):2627–2633.
22.
O'BrienJMBartonJRDonaldsonES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175(6):1632–1638.
23.
AmsalemHKingdomJCFarineD. Planned caesarean hysterectomy versus “conserving” caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011;33(10):1005–1010.
24.
SentilhesLAmbroselliCKayemG. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526–534.
AnanthCVSmulianJCVintzileosAM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol. 1997;177(5):1071–1078.
30.
OnwereCGurol-UrganciICromwellDAMahmoodTATempletonAvan der MeulenJH. Maternal morbidity associated with placenta praevia among women who had elective caesarean section. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):62–66.
31.
BetranAPMerialdiMLauerJA. Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinatal Epidemiol. 2007;21(2):98–113.
32.
EarlUBulmerJNBrionesA. Placenta accreta: an immunohistological study of trophoblast populations. Placenta. 1987;8(3):273–282.
33.
WellsMBulmerJN. The human placental bed: histology, immunohistochemistry and pathology. Histopathology. 1988;13(5):483–498.
34.
KhongTYRobertsonWB. Placenta creta and placenta praevia creta. Placenta. 1987;8(4):399–409.
35.
WehrumMJBuhimschiIASalafiaC. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol. 2011;204(5):411 e411–411 e411.
36.
HannonTInnesBALashGEBulmerJNRobsonSC. Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta—an immunohistochemical study. Placenta. 2012;33(12):998–1004.
37.
CliftonVL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31 suppl:S33–S39.
38.
KhongTYStaplesAChanASKeaneRJWilkinsonCS. Pregnancies complicated by retained placenta: sex ratio and relation to pre-eclampsia. Placenta. 1998;19(8):577–580.
39.
WongHSZuccolloJTaitJPringleKC. Placenta accreta in the first trimester of pregnancy: sonographic findings. J Clin Ultrasound. 2009;37(2):100–103.
40.
ComstockCHLeeWVettrainoIMBronsteenRA. The early sonographic appearance of placenta accreta. J Ultrasound Med. 2003;22(1):19–23; quiz 24-16.
41.
RobinsonBKGrobmanWA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010;116(4):835–842.
